Skip to main content
. 2020 Jan 24;99(4):e18543. doi: 10.1097/MD.0000000000018543

Figure 2.

Figure 2

Survival analysis and the association with UBE2T expression and clinicopathologic factors. (A) Overall survival (OS) analysis demonstrated that LUAD with UBE2T-high had a more terrible prognosis than that with UBE2T-low (P < .01). (B) Age association with UBE2T expression. (C) Sex association with UBE2T expression. (D) Stage association with UBE2T expression. (E) T-stage association with UBE2T expression. (F) M-stage association with UBE2T expression. LUAD = lung adenocarcinoma, UBE2T = ubiquitin conjugating enzyme E2 T.